Transient elevation of liver transaminase after starting insulin therapy for diabetic ketosis or ketoacidosis in newly diagnosed type 1 diabetes mellitus

Diabetes Research and Clinical Practice

Volumn 64, Issue 1, 2004, Pages 27-32

  Takaike, Hiroko ^a   Uchigata, Yasuko ^a   Iwasaki, Naoko ^a   Iwamoto, Yasuhiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

ALT; AST; Diabetic ketoacidosis; Fatty liver; Type 1 diabetes

Indexed keywords

AMINOTRANSFERASE; INSULIN; LIVER ENZYME; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONCENTRATION RESPONSE; CONTRAST; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; DRUG EFFECT; ECHOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HISTOGRAM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; INTERMETHOD COMPARISON; KIDNEY; LIPID STORAGE; LIVER; MAJOR CLINICAL STUDY; STATISTICAL SIGNIFICANCE;

EID: 1342323609     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2003.10.017     Document Type: Article

References (17)

1. Belfiore F., Napoli E., Vecchio L.L. Increased activity of some enzymes in serum in cases of severely decompensated diabetes, with and without ketoacidosis. Clin. Chem. 18:1972;1403-1406.
2. Imagawa A., Hanafusa T., Miyagawa J., Matsuzawa Y. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibododies. N. Engl. J. Med. 342:2000;301-307.
3. Brian E.W., Schecher A.J., Persons E.L. Unusual glycogen storage in a case of diabetes mellitus. Arch Intern. Med. 59:1937;685-690.
4. Vallance-Owen J. Liver glycogen in diabetes mellitus. J. Clin. Pathol. 5:1952;42-53.
5. Goodman J. Hepatomegaly and diabetes mellitus. J. Clin. Pathol. 5:1953;42-53.
6. Bronstein H.D., Kantrowitz P.A., Schaffner F. Marked Enlargement of the liver and transient ascites associated with the treatment of diabetic acidosis. N. Engl. J. Med. 261:1959;1314-1318.
7. W.J. Manderson, F.R.C.P.G.M.T. McKiddie, M.R.C.P. Glasgow, D.J. Manners, D.Sc., J.R. Stark, Liver glycogen accumulation in unstable diabetes, Diabetes 17 (1968) 13-16.
8. Ohno T., Horio F., Tanaka S., Terada M., Namikawa T., Kitoh J. Fatty liver and hyperlipidemia in IDDM (insulin-dependent diabetes mellitus) of streptozotocin-related shrews. Life Sci. 66(2):2000;125-131.
9. World Health Organization, Report of a WHO Study Group Second Report, Genova, Tech. Rep. Ser. 727 (1985) 1-113.
10. Kimura S. Quantitative estimation of liver-kidney contrast using echo-histogram analysis in diffuse liver diseases and renal diseases. Jpn. J. Med. Ultrasonics. 13:1986;425-433. (Japanese).
11. Weidman S.W., Ragland J.B., Fischer J.N. Jr., Kitabchi A.E., Sabesin S.M. Effects of insulin on plasma lipoproteins in diabetic ketoacidosis: evidence for a change in high density lipoprotein composition during treatment. J. Lipid Res. 23:1982;171-182.
12. Joven J., Rubies-Prat J., De La Figuera M. High density lipoprotein changes during treatment of diabetic ketoacidosis. Diabetes Metab. 11:1985;102-105.
13. Foster D.W., McGarrry J.D. The metabolic derangements and treatment of diabetic Ketoacidosis. N. Engl. L. Med. 309:1983;159-169.
14. Fleischmann M., Ivnedjian P.B. Regulation of sterol regulatory-element binding protein 1 gene expression in liver: role of insulin and protein kinase. Biochem. J. 349:2000;13-17.
15. Foretz M., Pacot C., Dugail I., Lemarchand P., Guichard C., Lipvre X.L., Lubrano C.B., Spiegelman B., Kim J.B., Ferre P., Foufelle F. ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose. Mol. Cell. Biol. 19:1999;3760-3768.
16. Shimomura I., Bashmakov Y., Ikemoto S., Horton J.D., Brown M.S., Gpldstein J.L. Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. Proc. Natl. Acad. Sci. U.S.A. 96(24):1999;13656-13661.
17. I. Shimomura, Y. Bashmakov, J.D. Horton, Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus, J. Biol. Chem. 274 (42) 30028-30032.